General News

Sonolith i-move receives approval in Japan

EDAP TMS' latest lithotripter, Sonolith® i-move, receives market approval from the Japanese Health Authorities. This approval is a milestone for Sonolith® i-move as Japan is the first lithotripter market worldwide. The full range of Sonolith® lithotripters is now available on the Japanese market enabling to cover the market needs with a high tech modular device (Sonolith® i-move) and a high-end device (Sonolith® i-sys).

Share |